These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34021124)

  • 1. Long non-coding RNA TUG1/microRNA-187-3p/TESC axis modulates progression of pituitary adenoma via regulating the NF-κB signaling pathway.
    Zhang R; Yang F; Fan H; Wang H; Wang Q; Yang J; Song T
    Cell Death Dis; 2021 May; 12(6):524. PubMed ID: 34021124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA TUG1 sponges microRNA-381-3p to facilitate cell viability and attenuate apoptosis in cervical cancer by elevating MDM2 expression.
    Liu J; Wu D; Lin X; Hong Y; Wang X; Zheng C; Wu Z; Hong Y; Lv Y
    Life Sci; 2021 Feb; 267():118902. PubMed ID: 33340525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of the lncRNA
    Zhang B; Zhao C; Hou L; Wu Y
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1125-F1134. PubMed ID: 33135476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
    Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling
    Dai T; Liang J; Liu W; Zou Y; Niu F; Li M; Zhang H; Li C; Fan M; Cui G
    Bioengineered; 2021 Dec; 12(2):10771-10781. PubMed ID: 34793263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TUG1 contributes to ESCC progression via regulating miR-148a-3p/MCL-1/Wnt/β-catenin axis in vitro.
    Tang Y; Yang P; Zhu Y; Su Y
    Thorac Cancer; 2020 Jan; 11(1):82-94. PubMed ID: 31742924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of TUG1 by shRNA inhibited renal cell carcinoma formation by miR-299-3p/VEGF axis in vitro and in vivo.
    Li Y; Zheng D; Pan L; Dai Y; Cai S; Zhao L; Zhu H
    Eur J Pharmacol; 2019 Oct; 860():172536. PubMed ID: 31310753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA TUG1 promotes the development of oral squamous cell carcinoma by regulating the MAPK signaling pathway by sponging miR-593-3p.
    Jiang L; Zhou B; Fu D; Cheng B
    Cell Cycle; 2022 Sep; 21(17):1856-1866. PubMed ID: 35604743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TUG1 promotes Ewing's sarcoma cell proliferation, migration, and invasion via the miR-199a-3p-MSI2 signaling pathway.
    Li H; Huang F; Liu XQ; Liu HC; Dai M; Zeng J
    Neoplasma; 2021 May; 68(3):590-601. PubMed ID: 33780263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MEG8 promotes TNF-α expression by sponging miR-454-3p in bone-invasive pituitary adenomas.
    Zhu HB; Li B; Guo J; Miao YZ; Shen YT; Zhang YZ; Zhao P; Li CZ
    Aging (Albany NY); 2021 May; 13(10):14342-14354. PubMed ID: 34016788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA TUG1 Promotes Proliferation and Inhibits Apoptosis of Osteosarcoma Cells by Sponging miR-132-3p and Upregulating SOX4 Expression.
    Li G; Liu K; Du X
    Yonsei Med J; 2018 Mar; 59(2):226-235. PubMed ID: 29436190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of TUG1/miRNA-299-3p Axis Represses Pancreatic Cancer Malignant Progression via Suppression of the Notch1 Pathway.
    Xu K; Zhang L
    Dig Dis Sci; 2020 Jun; 65(6):1748-1760. PubMed ID: 31655908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
    Shi P; Zhang J; Li X; Li W; Li H; Fu P
    Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA TUG1 regulates the balance of HuR and miR-29b-3p and inhibits intestinal epithelial cell apoptosis in a mouse model of ulcerative colitis.
    Tian Y; Wang Y; Li F; Yang J; Xu Y; Ouyang M
    Hum Cell; 2021 Jan; 34(1):37-48. PubMed ID: 33047284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
    Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
    Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200b-3p accelerates progression of pituitary adenomas by negatively regulating expression of RECK.
    Wang X; Jia Y; Li Q; Yang Q; Liu Y; Wei B; Niu X; Zhang Y; Luo X; Zhao Z; Wang P
    Oncol Res; 2024; 32(5):933-941. PubMed ID: 38686051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.